Literature DB >> 24761970

Time-domain T-wave alternans is strongly associated with a history of ventricular fibrillation in patients with Brugada syndrome.

Yuko Uchimura-Makita1, Yukiko Nakano1, Takehito Tokuyama1, Mai Fujiwara1, Yoshikazu Watanabe1, Akinori Sairaku1, Hiroshi Kawazoe1, Hiroya Matsumura1, Nozomu Oda1, Hiroki Ikanaga1, Chikaaki Motoda1, Kenta Kajihara2, Noboru Oda3, Richard L Verrier4, Yasuki Kihara1.   

Abstract

AIMS: T-wave alternans (TWA) is an indicator of vulnerability to ventricular arrhythmias and is useful for predicting sudden cardiac death (SCD) in patients with various structural heart diseases. We evaluated whether high levels of time-domain TWA on ambulatory ECG (AECG) are associated with a history of ventricular fibrillation (VF) in Brugada syndrome (BrS) patients. METHODS AND
RESULTS: We examined the associations among VF history, family history of SCD, spontaneous type 1 electrocardiogram (ECG), late potentials, VF induction by programmed electrical stimulation, and TWA in 45 BrS patients (44 males; mean age, 45 ± 15 years). TWA analyzed from 24-h AECG recordings using the modified moving average method was positive in 13 of 43 patients (30%). Patients with a history of VF had a significantly higher incidence of a positive TWA test (82% vs. 13%; P < 0.001) and spontaneous type 1 ECG (92% vs. 38%; P = 0.007) than those without VF history. Multivariate analysis indicated that positive TWA (OR 7.217; 95% CI 2.503-35.504; P = 0.002) and spontaneous type 1 ECG (OR 5.530; 95% CI 1.651-34.337; P = 0.020) were closely associated with VF history. Spontaneous type 1 ECG had high sensitivity (92%) but low specificity (63%). Positive TWA was a reliable marker with high sensitivity and specificity (82% and 88%, respectively).
CONCLUSION: Elevated time-domain TWA on AECG confirms arrhythmia risk in symptomatic BrS patients without the need for provocative stimuli.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  Brugada syndrome; T-wave alternans; ambulatory monitoring; implantable cardioverter-defibrillator; sudden death; ventricular fibrillation

Mesh:

Year:  2014        PMID: 24761970     DOI: 10.1111/jce.12441

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  14 in total

Review 1.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

Review 2.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-07-13       Impact factor: 6.343

3.  The utility of T-wave alternans during the morning in the summer for the risk stratification of patients with Brugada syndrome.

Authors:  Shogo Sakamoto; Masahiko Takagi; Jun Kakihara; Yusuke Hayashi; Atsushi Doi; Kenichi Sugioka; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2016-08-01       Impact factor: 2.037

4.  2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry.

Authors:  Jonathan S Steinberg; Niraj Varma; Iwona Cygankiewicz; Peter Aziz; Paweł Balsam; Adrian Baranchuk; Daniel J Cantillon; Polychronis Dilaveris; Sergio J Dubner; Nabil El-Sherif; Jaroslaw Krol; Malgorzata Kurpesa; Maria Teresa La Rovere; Suave S Lobodzinski; Emanuela T Locati; Suneet Mittal; Brian Olshansky; Ewa Piotrowicz; Leslie Saxon; Peter H Stone; Larisa Tereshchenko; Mintu P Turakhia; Gioia Turitto; Neil J Wimmer; Richard L Verrier; Wojciech Zareba; Ryszard Piotrowicz
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-05       Impact factor: 1.468

5.  Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.

Authors:  Jun Kakihara; Masahiko Takagi; Yusuke Hayashi; Hiroaki Tatsumi; Atsushi Doi; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2017-03-31       Impact factor: 2.037

Review 6.  Brugada Syndrome:Risk Stratification And Management.

Authors:  Yoshifusa Aizawa
Journal:  J Atr Fibrillation       Date:  2016-10-31

7.  Utility of T-wave alternans during night time as a predictor for ventricular fibrillation in patients with Brugada syndrome.

Authors:  Shogo Sakamoto; Masahiko Takagi; Hiroaki Tatsumi; Atsushi Doi; Kenichi Sugioka; Akihisa Hanatani; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2015-05-20       Impact factor: 2.037

8.  Brugada Syndrome: Defining the Risk in Asymptomatic Patients.

Authors:  Juan Sieira; Pedro Brugada
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 9.  Pathogenesis and management of Brugada syndrome.

Authors:  Juan Sieira; Gregory Dendramis; Pedro Brugada
Journal:  Nat Rev Cardiol       Date:  2016-09-15       Impact factor: 32.419

10.  Restitution metrics in Brugada syndrome: a systematic review and meta-analysis.

Authors:  Gary Tse; Sharen Lee; Mengqi Gong; Panagiotis Mililis; Dimitrios Asvestas; George Bazoukis; Leonardo Roever; Kamalan Jeevaratnam; Sandeep S Hothi; Ka Hou Christien Li; Tong Liu; Konstantinos P Letsas
Journal:  J Interv Card Electrophysiol       Date:  2019-12-14       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.